TY - JOUR
T1 - Factors Associated With Graft Rejection in the Cornea Preservation Time Study
AU - Cornea Preservation Time Study Group
AU - Stulting, R. Doyle
AU - Lass, Jonathan H.
AU - Terry, Mark A.
AU - Benetz, Beth Ann
AU - Cohen, Nathan J.
AU - Ayala, Allison R.
AU - Maguire, Maureen G.
AU - Croasdale, Christopher
AU - Daoud, Yassine J.
AU - Dunn, Steven P.
AU - Goins, Kenneth M.
AU - Gupta, Pankaj C.
AU - Macsai, Marian S.
AU - Mian, Shahzad I.
AU - Pramanik, Sudeep
AU - Rose-Nussbaumer, Jennifer
AU - Song, Jonathan C.
AU - Stark, Walter J.
AU - Sugar, Alan
AU - Verdier, David D.
AU - Szczotka-Flynn, Loretta B.
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Purpose: To identify factors related to graft rejection following Descemet stripping automated endothelial keratoplasty (DSAEK) in the Cornea Preservation Time Study (CPTS). Design: Cohort study within a multicenter randomized clinical trial. Methods: A total of 1330 eyes of 1090 subjects undergoing DSAEK were randomized to receive a donor cornea with preservation time (PT) of 0–7 days (n = 675) or 8–14 days (n = 655) and followed for 3 years. Central endothelial cell density (ECD) was determined by a central image analysis reading center. Multivariable Cox models adjusted for PT, recipient diagnosis, and surgeon effect were used to identify factors associated with rejection. Results: Cumulative probability of definite graft rejection was 3.6% (99% confidence interval 2.5%–5.3%). Younger recipient age was associated with graft rejection (P <.001; hazard ratio: 0.53 [0.33, 0.83] per decade). PT, donor–recipient sex mismatch, recipient diagnosis, recipient race, graft size, discontinuation of topical corticosteroids and immune-modulators, prior immunizations within 3 months, and prior glaucoma surgery were not associated with rejection (P >.01). Among clear grafts with an ECD measurement at baseline and 3 years (n = 913), endothelial cell loss (ECL) was greater in eyes that experienced a rejection episode (n = 27) than in those that did not (n = 886) (48% vs 38%, P =.03). Twelve of 44 eyes (27%) with definite graft rejection subsequently failed, comprising 15% of the 79 failures in the CPTS. Conclusions: Graft rejection is uncommon after DSAEK and more likely with younger age, in a study cohort mostly > 50 years old. Rejection increases ECL, but it is not a leading cause of DSAEK failure.
AB - Purpose: To identify factors related to graft rejection following Descemet stripping automated endothelial keratoplasty (DSAEK) in the Cornea Preservation Time Study (CPTS). Design: Cohort study within a multicenter randomized clinical trial. Methods: A total of 1330 eyes of 1090 subjects undergoing DSAEK were randomized to receive a donor cornea with preservation time (PT) of 0–7 days (n = 675) or 8–14 days (n = 655) and followed for 3 years. Central endothelial cell density (ECD) was determined by a central image analysis reading center. Multivariable Cox models adjusted for PT, recipient diagnosis, and surgeon effect were used to identify factors associated with rejection. Results: Cumulative probability of definite graft rejection was 3.6% (99% confidence interval 2.5%–5.3%). Younger recipient age was associated with graft rejection (P <.001; hazard ratio: 0.53 [0.33, 0.83] per decade). PT, donor–recipient sex mismatch, recipient diagnosis, recipient race, graft size, discontinuation of topical corticosteroids and immune-modulators, prior immunizations within 3 months, and prior glaucoma surgery were not associated with rejection (P >.01). Among clear grafts with an ECD measurement at baseline and 3 years (n = 913), endothelial cell loss (ECL) was greater in eyes that experienced a rejection episode (n = 27) than in those that did not (n = 886) (48% vs 38%, P =.03). Twelve of 44 eyes (27%) with definite graft rejection subsequently failed, comprising 15% of the 79 failures in the CPTS. Conclusions: Graft rejection is uncommon after DSAEK and more likely with younger age, in a study cohort mostly > 50 years old. Rejection increases ECL, but it is not a leading cause of DSAEK failure.
UR - http://www.scopus.com/inward/record.url?scp=85055293668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055293668&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2018.10.005
DO - 10.1016/j.ajo.2018.10.005
M3 - Article
C2 - 30308200
AN - SCOPUS:85055293668
SN - 0002-9394
VL - 196
SP - 197
EP - 207
JO - American journal of ophthalmology
JF - American journal of ophthalmology
ER -